Literature DB >> 3117375

Identification, isolation, and characterization of a novel cytotoxin in murine cytolytic lymphocytes.

C C Liu1, M Steffen, F King, J D Young.   

Abstract

Murine cytotoxic T lymphocytes contain, in addition to the cytotoxic pore-forming protein perforin, another cytolytic factor localized in both cytoplasm and granules. Like perforin, this CTL cytotoxin lyses a variety of tumor cells; unlike perforin, it is stable in the presence of calcium, requires several hours to induce maximal lytic activity, and is antigenically related to the previously described tumor necrosis factor (TNF) and lymphotoxin (LT). However, it differs from TNF and LT in a number of biochemical and functional properties. TNF- and LT-specific cDNA probes did not hybridize with any CTL-specific message, indicating that the CTL cytotoxin is distinct from those two factors. It has an apparent Mr of 50 and 70 kd under reducing and nonreducing conditions, respectively, is secreted by secretagogue-stimulated CTLs, and causes DNA fragmentation in several targets, a phenomenon previously attributed to target cell damage by CTLs. These results suggest that killing by lymphocytes may encompass multiple mechanisms and polypeptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117375     DOI: 10.1016/0092-8674(87)90635-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  26 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells.

Authors:  J P Tite
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

3.  Casein expression in cytotoxic T lymphocytes.

Authors:  M J Grusby; S C Mitchell; N Nabavi; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells.

Authors:  D L Thiele; P E Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  Resistance of tumor cells to tumor necrosis factor.

Authors:  H M Shepard; G D Lewis
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

6.  Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9.

Authors:  D M Lowrey; T Aebischer; K Olsen; M Lichtenheld; F Rupp; H Hengartner; E R Podack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 7.  Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK).

Authors:  C Gambacorti-Passerini; L Rivoltini; M Radrizzani; R Supino; M Mariani; G Parmiani
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

8.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  A role for perforin in downregulating T-cell responses during chronic viral infection.

Authors:  M Matloubian; M Suresh; A Glass; M Galvan; K Chow; J K Whitmire; C M Walsh; W R Clark; R Ahmed
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Resistance of HER2/neu-overexpressing tumor targets to lymphokine-activated-killer-cell-mediated lysis: evidence for deficiency of binding and post-binding events.

Authors:  C Fady; A Gardner; J F Gera; A Lichtenstein
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.